Role of Dexamethasone in Acute Psoriasis Treatment

Corticosteroids in Psoriasis Management

The American College of Rheumatology recommends using topical corticosteroids as the preferred approach for localized psoriatic lesions, particularly when combined with vitamin D analogues 3
Local corticosteroid injections are recommended as adjunctive therapy for psoriatic arthritis, enthesitis, or dactylitis, as suggested by the European League Against Rheumatism 1, 4, 5
Systemic steroids should only be used at the lowest effective dose and with significant caution in psoriasis patients, according to the National Psoriasis Foundation 2, 6

Skin flares may occur during treatment or upon tapering of systemic corticosteroids like dexamethasone, as reported by the American Academy of Dermatology 5, 6
Rebound phenomenon is a significant concern, where psoriasis may worsen dramatically after discontinuation of systemic steroids, as documented by the European Academy of Dermatology and Venereology 7

For localized disease, the American Academy of Dermatology recommends combination therapy with vitamin D analogues and topical corticosteroids 3
For moderate-to-severe disease, the European League Against Rheumatism suggests disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, which treats both skin and joint manifestations 8, 9

Systemic corticosteroids should only be used in exceptional circumstances when other therapies have failed or are contraindicated, as recommended by the National Psoriasis Foundation 2, 5
The European League Against Rheumatism suggests using systemic corticosteroids at the lowest effective dose and for the shortest duration possible 4, 6

The American Academy of Dermatology recommends monitoring patients closely for signs of steroid-induced complications including hypopigmentation, hypertrichosis, and acne 10
The European Academy of Dermatology and Venereology suggests tapering of systemic corticosteroids must be done gradually to minimize risk of rebound 5, 6